Q Fever (Coxiella Burnetii)

被引:37
|
作者
Pablo Espana, Pedro [1 ]
Uranga, Ane [1 ]
Cilloniz, Catia [2 ,3 ,4 ,5 ]
Torres, Antoni [2 ,3 ,4 ,5 ]
机构
[1] Univ Hosp Galdakao Usansolo, Dept Pulmonol, Bilbao, Spain
[2] Hosp Clin Barcelona, Dept Pneumol, Barcelona, Spain
[3] Univ Barcelona, August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain
[4] Biomed Res Networking Centers Resp Dis CIBERES, Barcelona, Spain
[5] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain
关键词
Coxiella burnetii; Q fever; epidemiology; pathogenesis; antigenic phase variation; diagnosis; treatment; COGNITIVE-BEHAVIORAL THERAPY; PHASE-I; EPIDEMIOLOGIC FEATURES; DOXYCYCLINE TREATMENT; FOLLOW-UP; RAW-MILK; INFECTION; DIAGNOSIS; ENDOCARDITIS; MONOCYTES;
D O I
10.1055/s-0040-1710594
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Q fever is a zoonotic infectious disease caused by theCoxiella burnetiibacterium. It is an obligate intracellular pathogen with a high infection capacity that proliferates exclusively in an acidified medium, forming a lysosome-like vacuole. It presents a peculiar phenomenon called "antigenic phase variation," produced by a modification in the complexity of the membrane lipopolysaccharides. Q fever can be found worldwide and presents variable clinical features and geographical distribution. It mostly affects people in rural areas who are in contact with animals. The most common type of transmission to humans is via the inhalation of aerosols containing the pathogen, especially those formed from placental derivatives. Wild animals, domestic animals, and ticks are the principal reservoirs. Diagnosis is mainly made by indirect methods such as serology or by direct methods such as microbiological cultures or tests that detect the specific DNA. Typically, there are two clinical presentations: the acute disease, which is more frequent and often asymptomatic, and a persistent focalized infection in 4 to 5% of patients, generally with a poor evolution. Treatment of the acute form in both children and adults consists of administering doxycycline, while persistent focalized infection should be treated with at least two antibiotics, such as doxycycline and hydroxychloroquine. Several measures should be undertaken to minimize exposure among people working with animals or handling birth products. Different vaccines have been developed to prevent infection, though few data are available.
引用
收藏
页码:509 / 521
页数:13
相关论文
共 50 条
  • [21] Animal Models of Q Fever (Coxiella burnetii)
    Bewley, Kevin R.
    COMPARATIVE MEDICINE, 2013, 63 (06) : 469 - 476
  • [22] Protein array of Coxiella burnetii probed with Q fever sera
    Wang XiLe
    Xiong XiaoLu
    Graves, Stephen
    Stenos, John
    Wen BoHai
    SCIENCE CHINA-LIFE SCIENCES, 2013, 56 (05) : 453 - 459
  • [23] Seroprevalence of Q fever ( Coxiella burnetii) in sheep in the Kwahu West municipality, Eastern Region, Ghana
    Abbiw, Richard Kwamena
    Mensah, Gloria Ivy
    Adabie-Gomez, Delphina A. M.
    Asare-Dompreh, Kweku
    Clement-Owusu, Stephanie
    Adjei, Vida Yirenkyiwaa
    Simpson, Shirley Victoria
    Ahmed, Mustapha Abubakar
    Johnson, Sherry A. M.
    HELIYON, 2024, 10 (12)
  • [24] The Correlation of Q Fever and Coxiella burnetii DNA in Household Environments in Rural Senegal
    Ratmanov, Pavel
    Bassene, Hubert
    Fenollar, Florence
    Tall, Adama
    Sokhna, Cheikh
    Raoult, Didier
    Mediannikov, Oleg
    VECTOR-BORNE AND ZOONOTIC DISEASES, 2013, 13 (01) : 70 - 72
  • [25] Mononeuritis multiplex caused by Coxiella burnetii infection (Q fever)
    Sommer, JB
    Schoerner, C
    Heckmann, JG
    Neundoerfer, B
    Hilz, MJ
    ACTA NEUROLOGICA SCANDINAVICA, 2002, 106 (06): : 371 - 373
  • [26] Seroprevalence of horses to Coxiella burnetii in an Q fever endemic area
    Desjardins, Isabelle
    Joulie, Aurelien
    Pradier, Sophie
    Lecollinet, Sylvie
    Beck, Cecile
    Vial, Laurence
    Dufour, Philippe
    Gasqui, Patrick
    Legrand, Loic
    Edouard, Sophie
    Sidi-Boumedine, Karim
    Rousset, Elodie
    Jourdain, Elsa
    Leblond, Agnes
    VETERINARY MICROBIOLOGY, 2018, 215 : 49 - 56
  • [27] Seroprevalence of Coxiella burnetii in Australian dogs
    Shapiro, A. J.
    Norris, J. M.
    Heller, J.
    Brown, G.
    Malik, R.
    Bosward, K. L.
    ZOONOSES AND PUBLIC HEALTH, 2016, 63 (06) : 458 - 466
  • [28] Coxiella burnetii - Pathogenic Agent of Q (Query) Fever
    Guertler, Lutz
    Bauerfeind, Ursula
    Bluemel, Johannes
    Burger, Reinhard
    Drosten, Christian
    Groener, Albrecht
    Heiden, Margarethe
    Hildebrandt, Martin
    Jansen, Bernd
    Offergeld, Ruth
    Pauli, Georg
    Seitz, Rainer
    Schlenkrich, Uwe
    Schottstedt, Volkmar
    Strobel, Johanna
    Willkommen, Hannelore
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2014, 41 (01) : 60 - 72
  • [29] Clinical Features and Complications of Coxiella burnetii Infections From the French National Reference Center for Q Fever
    Melenotte, Clea
    Protopopescu, Camelia
    Million, Matthieu
    Edouard, Sophie
    Carrieri, M. Patrizia
    Eldin, Carole
    Angelakis, Emrnanouil
    Djossou, Felix
    Bardin, Nathalie
    Fournier, Pierre-Edouard
    Mege, Jean-Louis
    Raoult, Didier
    JAMA NETWORK OPEN, 2018, 1 (04)
  • [30] Unreliability of three commercial Coxiella burnetii phase II IgM ELISA kits for the seroscreening of acute Q fever in human cases
    Stephen, Selvaraj
    Ambroise, Stanley
    Pradeep, Jothimani
    Gunasekaran, Dhandapany
    Sangeetha, Balakrishnan
    Sarangapani, Kengamuthu
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 146 : 386 - 391